Clinical Trials Logo

Peripheral Vertigo. clinical trials

View clinical trials related to Peripheral Vertigo..

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01890538 Completed - Peripheral Vertigo Clinical Trials

Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo

Start date: June 2013
Phase: Phase 4
Study type: Interventional

This study aims to investigate efficacy of two different intravenous drugs (dimenhydrinate and piracetam) in the symptomatic management of peripheral vertigo. The patients will be randomized in two groups according to symptomatic treatment modalities: Dimenhydrinate (100 mg) and piracetam (2 g) will be given in 100 cc normal saline in 30 minutes. Each patient will be asked if her/his vertigo symptoms resolved or not, according to a numeric rating scale (0=no vertigo, 10=worst possible vertigo). The patient will be rate the intensity of symptoms in the following times: - Numeric rating scale (1 to 10): Admission - Numeric rating scale (1 to 10): After the study drug (No ambulation)* - Numeric rating scale (1 to 10): After the study drug (Ambulation)* - Ambulation refers to head movements or walking in the room, if applicable.

NCT ID: NCT01827293 Completed - Peripheral Vertigo. Clinical Trials

Promethazine vs. Lorazepam for Treatment of Vertigo

Start date: April 2013
Phase: Phase 3
Study type: Interventional

This study was a prospective, randomized, double-blind, parallel group clinical trial designed to compare the efficacy of intravenous (IV) promethazine and lorazepam for the treatment of peripheral vertigo in Emergency Department setting.